Found 21 matching trials
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia PHASE2 This trial aims to demonstrate the feasibility of this approach to reliably...
Show More Location
AHN Cancer Institute - West Penn Hospital
Learn More & Join Trial
CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) PHASE1 Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, ...
Show More Location
Multiple Locations
Learn More & Join Trial
CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell Malignancies PHASE1 This study seeks to examine the feasibility and safety of the administratio...
Show More Location
Multiple Locations
Learn More & Join Trial
Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts N/A Allogeneic stem cell transplantation (alloSCT) is utilized for various unde...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy PHASE1 This is a single-center, non-randomized clinical study to evaluate the safe...
Show More Location
Shanghai Tongji Hospital, Tongji University School of Medicine
Learn More & Join Trial
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies PHASE1 This multicenter phase 1 trial with "3 + 3" dose escalation design seeks to...
Show More Location
University of Kansas Cancer Center
Learn More & Join Trial
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity PHASE1 The primary purpose of this phase I/II study is to evaluate whether partial...
Show More Learn More & Join Trial
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab PHASE1 The objective of this clinical trial is to develop a cell therapy for Fanco...
Show More Location
Stanford University
Learn More & Join Trial
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies PHASE2 Patients less than or equal to 21 years old with high-risk hematologic mali...
Show More Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections PHASE1 This open-label, single-arm, phase I/II clinical trial will assess the safe...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial